What was recalled
This page synthesizes the AAFCO Nutrient Profiles framework around sodium in dog and cat diets and the clinical thresholds used in veterinary therapeutic diet formulation. The AAFCO Dog Food Nutrient Profiles specify minimum sodium at 0.08% dry matter for adult maintenance and 0.3% for growth and reproduction. The AAFCO Cat Food Nutrient Profiles specify minimum sodium at 0.2% dry matter for adult maintenance and growth/reproduction, with maximum sodium of 1.5% dry matter for adult cats (no maximum specified for dogs). The minima support normal physiology including extracellular fluid balance, nerve transmission, and acid-base regulation. The maxima for cats are set to prevent calculated overload in obligate carnivores with limited urinary sodium excretion capacity.
Veterinary therapeutic diet thresholds for cardiac and chronic kidney disease (CKD) management differ from AAFCO minima. "Severely restricted" cardiac diets (Hill’s h/d, Royal Canin Early Cardiac, Royal Canin Cardiac) run 0.08-0.15% dry-matter sodium; "moderately restricted" CKD diets (Hill’s k/d, Royal Canin Renal Support) run 0.15-0.25% dry-matter sodium. The therapeutic threshold rationale is supported by veterinary cardiology and nephrology literature documenting clinical outcome differences at these sodium levels in patients with established disease. The thresholds do not apply to healthy pets, who tolerate the typical 0.2-0.5% retail formulation sodium range without nutritional concern.
Why it was recalled
The consumer-facing translation controversy stems from human-nutrition framing where sodium reduction is broadly recommended due to hypertension and cardiovascular disease prevalence. The dog and cat physiology differs substantially: essential hypertension as understood in human medicine is rare in dogs and uncommon in cats; sodium-induced hypertension in dogs and cats is primarily secondary to established kidney disease or cardiac disease rather than a primary disease process. The consumer-facing assumption that "low sodium = healthier" therefore does not translate directly to pet nutrition for healthy pets.
The retail "low sodium" marketing claim carries no AAFCO-defined threshold equivalent to veterinary therapeutic diet sodium levels. A retail product marketed as "low sodium" may still contain 0.3-0.4% dry-matter sodium — substantially above the 0.08-0.15% threshold used in veterinary cardiac therapeutic diets. Pet owners managing cardiac or CKD diagnoses should not substitute retail "low sodium" products for veterinary-prescribed therapeutic diets without specific veterinary direction. The AAFCO Official Publication and the American College of Veterinary Internal Medicine (ACVIM) consensus statements provide the technical references.
Health risks for your pet
Sodium-related health risks in dogs and cats include: (1) cardiac decompensation in dogs and cats with established heart disease who consume sodium above the moderate-restriction threshold; (2) CKD progression in cats and dogs with established kidney disease who consume sodium above the moderate-restriction threshold; (3) hypernatremia from acute high-sodium ingestion (typically from salt water, brine, or playdough ingestion rather than commercial pet food); (4) secondary hypertension in pets with established kidney or adrenal disease. Healthy adult dogs and cats consuming typical commercial pet food (0.2-0.5% dry-matter sodium) do not experience adverse effects from the sodium content. The AAFCO maximum for cats (1.5% dry matter) is rarely approached in commercial products. Sodium deficiency from below-AAFCO-minimum diets can produce muscle weakness, fatigue, and poor growth in young animals, but commercial products meeting AAFCO Nutrient Profiles are above the deficiency threshold by design.
What to do if you bought affected product
Pet owners can navigate the sodium content question through: (1) healthy pet feeding — typical commercial pet food sodium content (0.2-0.5% dry matter) is not nutritionally concerning for healthy dogs and cats; do not over-restrict sodium in healthy pets; (2) cardiac patient management — pets diagnosed with cardiac disease (mitral valve disease, dilated cardiomyopathy, hypertrophic cardiomyopathy) require veterinary-prescribed cardiac therapeutic diets (sodium 0.08-0.15% dry matter); retail "low sodium" claims do not match this threshold; (3) CKD patient management — cats and dogs with diagnosed chronic kidney disease benefit from moderate sodium restriction (0.15-0.25% dry matter) combined with phosphorus restriction and adequate hydration; veterinary-prescribed renal diets meet the combined restrictions; (4) label reading — pet food sodium content is typically not listed on the front-of-bag; the AAFCO Guaranteed Analysis includes sodium for some products, and manufacturer nutritional information typically provides the dry-matter sodium calculation on request. The guaranteed analysis labeling controversy covers the broader labeling framework.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not heavily penalize moderate sodium content in healthy-pet formulations per our published methodology, recognizing that the AAFCO-aligned 0.2-0.5% dry-matter sodium range is nutritionally appropriate for healthy adult pets. Excessive sodium content (above 0.6% dry matter) receives modest scoring penalty for the secondary-effect concern in undiagnosed pre-cardiac or pre-CKD patients. Veterinary therapeutic diet formulations are not scored on the retail-product rubric — the therapeutic diet sodium thresholds (0.08-0.25%) are clinical management tools rather than general-purpose feeding parameters. Pet owners with cardiac or CKD-diagnosed pets should work with their veterinarian to select an appropriate prescription diet rather than relying on retail "low sodium" marketing claims.